Pages that link to "Item:Q2455719"
From MaRDI portal
The following pages link to Cumulative cohort design for dose-finding (Q2455719):
Displaying 17 items.
- The treatment versus experimentation dilemma in dose finding studies (Q538132) (← links)
- Individualized dosing for multiple ordered groups of patients (Q2320813) (← links)
- Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
- Group up-and-down designs for dose-finding (Q2492509) (← links)
- Coherence principles in dose-finding studies (Q3545408) (← links)
- The role of minimal sets in dose finding studies (Q4559466) (← links)
- A new design of the continual reassessment method (Q5082671) (← links)
- Retrospective Analysis of Sequential Dose‐Finding Designs (Q5717156) (← links)
- Bias induced by adaptive dose-finding designs (Q5861424) (← links)
- Target toxicity design for phase I dose-finding (Q5880075) (← links)
- Longitudinal model for a dose-finding study for a rare disease treatment (Q6056990) (← links)
- Performance Measures in Dose‐Finding Experiments (Q6085864) (← links)
- Evaluation of early phase dose finding algorithms in heterogeneous populations (Q6541920) (← links)
- Statistical frameworks for oncology dose-finding designs with late-onset toxicities: a review (Q6577811) (← links)
- A simulation-free approach to assessing the performance of the continual reassessment method (Q6617412) (← links)
- Fractional accumulative calibration-free odds (f-aCFO) design for delayed toxicity in phase I clinical trials (Q6618310) (← links)
- uTPI: a utility-based toxicity probability interval design for phase I/II dose-finding trials (Q6627822) (← links)